A multimodal AI model identified a subset of men with very high-risk localized prostate cancer who derived substantial ...

There are around 46,000 new cases of prostate cancer each year in England and Wales, with 13% of these cases showing signs of ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...

One in eight men will develop prostate cancer in their lifetime. Surgery to treat the disease can lead to unwelcome side effects. A minimally invasive alternative that avoids surgery is now available ...

Study reveals geographic differences in the use of innovative technological approaches to diagnose and treat prostate cancer. The study looked at the effect of regional hospital competition and ...

A non-systematic literature review was conducted on PubMed, Scopus, and Web of Science up to March 15, 2024, for studies that assessed salvage treatment outcomes in patients with recurrent PCa after ...

Read more in the PNW Health series. Prostate cancer is the second-most common cancer among men in the U.S., affecting 13 out of every 100 American men over the course of their lifetime. About two to ...

Breaking news and analysis from time.com. Politics, world news, photos, video, tech reviews, health, science, and ...

RLTs were a hot topic at ASCO 2026, but experts note that certain limitations must be addressed to facilitate their ...

September is Prostate Cancer Awareness Month, a time to focus on the importance of early detection and treatment of a disease that affects 1 in 8 men during their lifetime. Early-stage prostate cancer ...

Long-used imaging strategies such as computed tomography (CT) and bone scintigraphy (BS) to detect lymph node and bone metastases have significant limitations and disadvantages. Newly emerging ...

Given the low mortality from slow-growing, localized prostate cancers and the side effects of many treatments, deciding whether to opt for monitoring or treatment can be excruciatingly difficult.